10.3389/fendo.2022.1033479 Front
Subsequent sections will provide recommendations for GLP-1based pharmacotherapy for individuals with additional CKM conditions including T2D (Section 5.5.1, Management of T2D in CKM Syndrome Stage 2 to 3), CKD (Section 5.5.4, Management of CKD in CKM Syndrome Stage 2 to 3), ASCVD (Section 6.2, Management of ASCVD ), HF (Section 6.3, Management of HF) and MASLD (Section 7.2, Metabolic DysfunctionAssociated Steatotic Liver Disease)
Yes, there can be side effects, although they are typically mild for most people
Our tester noted how deeply hydrated her under-eyes were after using them and loved how they improved concealer application
Weight loss, especially visceral weight loss, induced by the ketogenic diet can reduce estrogen levels by reducing systemic inflammation and hepatic metabolism, potentially also inhibiting the progression of endometriosis
Cosmetic treatments are also expected to rise as a solution for the facial results that come with rapid weight loss